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Abstract 
The World Health Organization estimates that more than 
70% of the world’s population, especially those who re-
side in the tropics, rely almost exclusively on plants as a 
primary source of medicines. Over the last decades an 
awareness has grown of the pharmacological potential of 
medicinal plants, and a potentially bright future for drugs 
developed from natural products. At the same time, the 
use of plants in medical practice contributes to the grow-
ing threat to species and ecosystem preservation. This 
paper expands the narrow view of plants as sources for 
pharmaceutical development to discuss botanical medi-
cine from an economic and human development perspec-
tive. I consider strategies that can ensure that the benefits 
that accrue from utilization of indigenous plant knowledge 
become positive forces for human development. Issues of 
sustainability are discussed vis à vis poverty, protection 
of ecosystems, and the potential for future use and long-
term viability of medicinal species. Issues of ownership 
also are presented in the context of intellectual property 
rights, with particular reference to the inadequacy of pat-
ent rights to protect indigenous knowledge. 
Introduction
Throughout the world, people use many wild species for 
food, medicine, clothing, shelter, fuel, fiber, income gen-
eration and for the fulfillment of cultural needs. There is a 
growing recognition that biological diversity including me-
dicinal plants is a global asset of tremendous value to the 
present and future generations. However, pressure from 
growing populations and the adoption of some modern life 
styles are threatening the existence of many of these spe-
cies and the ecosystems that support them. Loss of spe-
cies caused by human activities continues at an alarm-
ing rate. According to the FAO, 5.5 million hectares of re-
source lands are lost every year due to deforestation, cul-
tivation, over-grazing, burning, erosion, etc. (FAO, 1993). 
In forest habitats, whether of high timber value or not, 
medicinal plants are a major component of annually har-
vested non-timber forest products (NTFPs). They include 
herbs, vines, shrubs or trees from which medicine can be 
extracted from roots, wood, bark, leaves, flowers, fruit or 
seed. Medicinal plants are the primary source of medi-
cines used by traditional healers. Traditional birth atten-
dants, and many mothers in the home also harvest from 
wild sources, while maintaining the commonly used, high 
demand medicinal plants in home gardens. The World 
Health Organization estimates that as much as 80 per-
cent of the world’s population, especially those living in 
tropical countries rely almost exclusively on herbal prod-
ucts as the main form of medication. Indeed, for millions 
of Africans, traditional healers, who use botanical medi-
cines predominantly, are their only contact with medicine 
of any kind particularly in the rural areas where hospitals 
are rare and doctors are few. The majority of the people 
depend on treatments given by traditional healers and it 
is possible that this trend will continue for a long time to 
come. The increasing scarcity of medicinal plant species 
represents a trend that should be addressed immediately, 
otherwise many medicinal plant species that have sus-
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tained rural people for centuries may be lost forever. Thus, 
policies and procedures that enable medicinal plants to be 
used sustainably must be developed to check this threat. 
The principal objectives of the Convention on Biological 
Diversity (CBD), which was developed by an inter-gov-
ernmental negotiating committee, are the conservation 
and sustainable use of biological diversity and the fair 
and equitable sharing of benefits arising from its utiliza-
tion. The convention recognizes that the key to maintain-
ing biodiversity, including medicinal plants, depends upon 
using this diversity in a sustainable manner. The CBD also 
addresses the issue of bearing the burden and sharing 
of benefits fairly and equitably between developing and 
developed countries on one hand and indigenous / local 
communities and end users in modern sectors on the oth-
er. Therefore, ownership and sustainability concerns for 
the medicinal plants used in botanical medicine are ad-
equately covered by the CBD. The CBD was opened for 
signature at the United Nations Conference on Environ-
ment and Development (UNCED 1992) in Rio de Janeiro 
on 5th June 1992 and it entered into force on 29th Decem-
ber 1993. Currently, there are more than 177 parties (as of 
March 2005). Parties to the CBD are obliged to contribute 
to the convention’s objectives through the conservation 
and sustainable use of biological resources that abound 
within their territory. 
Sustainability and ownership issues are very pertinent if 
plant use in botanical medicine is to be meaningfully in-
tegrated, translated and applied to the traditional popula-
tions that that use them.
Botanical (Herbal) Medicine
Herbal medicine is part of traditional medicine, in which 
plants and other natural materials are utilized for preven-
tive and therapeutic purposes. Available records show 
that over 80% of the registered traditional medicine prac-
titioners make use of leaves, roots and bark of trees of 
medicinal plants in various forms. Thus, even though 
there is more involved in traditional medicines than just 
herbal remedies, medicinal plants may be regarded as 
the mainstay of traditional medicine practice. The WHO 
(1991) defined herbal medicine as finished, labeled me-
dicinal products that contain as active ingredients aerial 
or underground parts of plants, or other plant materials, 
or combinations thereof, whether in the crude state or as 
plant preparations. Plant material includes juices, gums, 
fatty oils, essential oils and any other substances of this 
nature. Herbal medicines may contain excipients in addi-
tion to the active ingredients. Herbal medicines may con-
tain by tradition, natural organic or inorganic ingredients 
which are not of plant origin. However, medicines con-
taining plant material combined with chemically defined 
active substances, including chemically defined, isolat-
ed constituents of plants are not considered to be herbal 
medicines. Medicinal plants have also been defined as 
any plant which in one or more of its organs contain sub-
stances including essential oils that can be used for treat-
ment purposes or which are precursors for the synthesis 
of useful drugs.
Sustainable Use of Medicinal Plants
Sustainable use as outlined in Articles 2, 5 and 10 of the 
CBD means the use of components of biological diversity 
in a way and at a rate that does not lead to the long-term 
decline of the resource.  The central idea of sustainability 
is that of ensuring that whatever action is taken, and how-
ever useful it might look at the time, its long-term effects 
must be assessed and if they are negative in the long run, 
they must be abandoned. Conversely, action that will have 
long-term beneficial effects should not be ignored in fa-
vour of short-term profitability. The convention recognizes 
the need to maintain the potentials of medicinal plants to 
meet the needs and aspirations of present and future gen-
eration. Therefore there is an existing framework that can 
be adopted by all the nations for the conservation of me-
dicinal plants.
Use of a species is likely to be sustainable if:
It is compatible with maintaining the ecosystem in 
which the species is found;
It does not reduce the future use potential and impair 
the long term viability of the species; and 
It does not reduce its future usefulness to humans.
The current mode of use of medicinal plants in botanical 
medicine at the grassroots level is a far cry from these re-
quirements and there is no indication that it will get better 
soon. The major concerns especially in Nigeria and other 
parts of the sub-Sahara Africa are as follows.
Major Concerns
Poverty
Poverty and herbal medicine are inter-related. Rural pov-
erty is both a cause and consequence of over-exploitation 
of natural resources and the resultant degradation of the 
environment. The poor are the ones that are usually prone 
to diseases. Most of our herbal practitioners live in the 
countryside where the standard of living is generally very 
poor. Generally, the rural communities depend entirely on 
forest resources for their sustenance in terms of food se-
curity, income, domestic energy and primary health care. 
In some communities, up to 80% of household materials, 
e.g. food, utensils, shelter, furniture, etc. are derived from 
forest plants. Provision of appropriate information con-
cerning sustainable means of harvesting and alternative 
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The mode of use of medicinal plants
The mode of herbal practice varies from country to coun-
try and from one community to the other. Practically every 
practitioner prepares his own remedies without reference 
to any universal protocol or formulated standards. The 
medicaments being produced are largely unstandard-
ized in quantity and uncontrolled in quality. This situation 
makes control and regulation of botanical medicines very 
difficult. Those of them who overharvest when collecting 
plants from the field are usually not aware of the harm be-
ing done. In some places, herbalists and other users boil 
their plant medicines using precious fuel wood collected 
from the same forest and by this practice add more insult 
to ecological injury. It is absolutely necessary to design 
alternative ways to harvest medicinal plants without en-
dangering them. 
Accredited formal training institutions are virtually non-ex-
istent. There is hardly any proper documentation of the 
diseases treated or the medicines being used. Due to high 
level of poverty, traditional healers employ low levels of 
technology in the preparation of their products. This type 
of approach makes regulation and control very difficult. In-
deed, herbal medicine practice today is an environmental 
and health emergency.
Loss of medicinal plant species 
and damage to ecosystem
The activity that consumes the highest number of species 
in sub-Saharan Africa today is herbal medicine. Most me-
dicinal plants are harvested with little or no regard to the fu-
ture. This is damaging both species and ecosystems. The 
damage is especially serious, when bark, roots, seeds, 
or flowers are removed, since these parts of the plant are 
essential for their reproduction. The emergence of com-
mercial medicinal plant gatherers in response to urban 
demand for medicines is an even greater danger. Con-
sidering the population of herbal users and the frequency 
of usage, significant volumes of plant materials are used. 
Several indigenous species have already been lost be-
cause of indiscriminate exploitation, and many more me-
dicinal plants face extinction or severe genetic loss.
Presently, there is little or no evidence of large-scale cul-
tivation of plants. Obviously, herbal medical practitioners 
lack the means or know-how for large-scale cultivation of 
medicinal plants. However, they can manage backyard 
gardens in their traditional localities. Sustainable forest 
management strategies should be developed which in-
clude those that permit local communities to use resourc-
es appropriately. When local communities see themselves 
as being involved and actually benefiting from combined 
efforts to conserve medicinal plants, they can be mobi-
lized for in-situ and ex-situ conservation. Some key spe-
cies that have been identified to be central to health care 
delivery in communities may be used in this manner. Sus-
tainable use strategies may be developed for such medic-
inal plants for preventive and curative medicines in com-
mercial quantities and in this way the economic status of 
the rural communities may be enhanced through proper 
management. 
Lack of Standardization
Standardization of herbal medicines is the process of es-
tablishing quality and identity profiles as well as unshared, 
unique features that can be used for the purpose of safety 
monitoring and overall quality assurance of herbal medi-
cines. Lack of standardization has hindered the regula-
tion and control of herbal medicine despite its existence 
over many centuries and its expansive use in most coun-
tries in the last decade. There is hardly any evidence of 
adequate control measures to ensure reproducibility and 
repeatability in terms of quality, safety, dosing and toxic-
ity at all stages of herbal medicine production. This situ-
ation makes people feel very reluctant to accept the use 
of botanical medicines even where there is proof of effica-
cy. The process of collection, drying, extraction, formula-
tion, and packaging must be standardized so that the ma-
terials in use may be classified, quantified and volumes 
estimated at any given time. We need standardization in 
order to define precisely the direction of use of medici-
nal plants and therefore their conservation. A set of such 
standards should be compiled in the form a monograph 
for each herbal medicine. Provision of a monograph in 
an Herbal Pharmacopoeia is evidence of standardiza-
tion, for that particular herbal medicine. Such sets of stan-
dards carry with them, an assurance of quality for moni-
toring safety, efficacy and reproducibility, which become 
the most essential parameters in their evaluation and any 
national drug regulatory requirements for a dossier. Such 
standards are complied with through all the stages of pro-
duction of such herbal medicine (Elujoba 1999). Recently, 
many international authorities and agencies including the 
World Health Organization have started creating a new 
mechanism to induce quality control and standardization 
of herbal medicine. 
Research and Development
In order to improve on the general acceptability and sus-
tainable use of botanical medicines and provide some sci-
entific validity, much research and development (R&D) 
work is needed to standardize the nomenclature, collec-
tion, extraction, processing, formulation procedures, qual-
ity, safety, dosage, indications, contra-indications, etc. 
The major drawback in R&D is low funding. R&D funds 
hardely exceed one percent of the GDP in developing 
countries. However, 2-4% of GDP is directed to R&D in 
industrialized countries. R&D can generate appropriate 
knowledge and add value to our medicinal plant resourc-
es locally and build technical capacity for improving the 
resources. Therefore botanical medicine should become 
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an important component of national economic develop-
ment strategy. 
Education and Training 
It is absolutely essential to focus on the development of 
the right caliber of manpower for botanical medicine at all 
levels. A formal training programme should be designed to 
replace the hereditary mode of knowledge transfer. Such 
training may be organized through relevant government 
institutions or non-government organizations. It is neces-
sary to organize a forum for exchange of information and 
to dialogue with traditional medical practitioners on a rou-
tine basis. This may be in the form of workshops, semi-
nars or courses to educate the traditional healers on some 
important aspects of their practice. 
Information Databank
Most of the knowledge on uses of medicinal plants is held 
by the traditional societies whose very existence is also 
under threat. Health traditions in Sub-Saharan Africa are 
being lost because they are oral and largely undocument-
ed. Proper and careful scientific documentation will ensure 
successful exploitation and conservation of the medicinal 
plants. Adequate pharmacopoeia information should be 
developed to replace the traditional method of knowledge 
transfer. There should be monographs of each medicinal 
plant that should be upgraded periodically. There is need 
to strengthen the information network on medicinal plants 
for their conservation. There is need for national databas-
es on medicinal plants and for these to link up with oth-
er international efforts (Thomas 2003). This may be de-
veloped through bio-geographic/socio-economic surveys 
and adoption of existing databases on medicinal plants 
so as to provide baseline information that is required to 
understand the values of medicinal plants to local com-
munities. 
Biotechnology
There is the need to strengthen indigenous capacity in 
biotechnology for medicinal plant conservation. Biotech-
nology (genetic engineering and related technologies) 
and cell culture techniques are widely employed in the 
improvement of plants and animals, and to make or mod-
ify products. Clonal micro-propagation of plants through 
tissue culture, protoplast fusion, embryo transfer and 
cryopreservation techniques contribute to genetic im-
provement of the plants and to conservation of valuable 
germ plasm. Application of recombinant DNA technolo-
gies can lead to development of transgenic plants with 
improved characteristics. Genetic engineering techniques 
can be used for identification of unique population using 
DNA fingerprints and valuable species with useful traits 
(e.g. insecticide properties) or genetically improved vari-
eties may be preserved through established germ plasm 
banks. Gene-banks can easily and economically store 
large amount of seeds of different species and include 
intraspecies variability. Gene-banks are therefore neces-
sary for conserving sufficient diversity of plants and their 
relatives to ensure that all their potentials are preserved 
for use in the future.
Ownership Issues
Ethical and economical issues are very important compo-
nents in the management aspects of herbal medicine de-
velopment. Issues of equity in the distribution of benefits 
from the use of medicinal plants and traditional crop vari-
eties have underlain international debates over biodiver-
sity for more than a decade  (Elisabetsky 1991).  
Unimproved genetic and biochemical resources are gen-
erally regarded as the common heritage of humankind 
(ownerless), freely accessible by anyone. However, de-
veloping countries are seriously worried about the system 
that labels their resources as “open access” but then es-
tablishes private ownership (property rights) for improved 
products based on these resources. They consider it un-
fair that individuals and companies based in the gene-
poor developed countries obtain resources free-of charge 
from the gene-rich developing countries, then patent the 
genes and chemicals and sell the patented products back 
to the country where they originated. Therefore, they of-
ten argue that intellectual property rights (IPR) should be 
modified in order to internalize the cost of biodiversity loss 
and management and to ensure that the source countries 
as custodians, receive more of the economic returns from 
its development. As a supplement to these property rights, 
formal and informal contracts have to be included to en-
sure just compensation for traditional medical knowledge 
(Laird 2002). 
Article 8 (j) of the CBD provides that subject to national 
legislation, the “knowledge, innovations and practices”, in 
other words, knowledge and technologies of indigenous 
and local communities shall be respected, preserved and 
maintained. Access to this knowledge and technologies 
shall be obtained with the prior informed consent and in-
volvement of the communities. The conference of the par-
ties to the CBD held in Bratislava, May 1998, ruled, “Na-
tional law could legally recognize Community Intellectual 
Rights”. The convention notes that countries should en-
courage the “equitable sharing of the benefits arising from 
the utilization of the knowledge, innovations and practic-
es of indigenous and local communities”. Therefore, if ex-
tending intellectual property rights to unimproved genetic 
resources fails to capture benefits from the use of me-
dicinal plant resources, contract agreements, and access 
restrictions and the promotion of value-added industries 
would. 
Basically, the arguments are as follows:
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Intellectual Property Rights (IPR)
Intellectual property consists of legal regimes aimed at 
encouraging inventiveness, creativity and commerce by 
granting inventors, creators and men of commerce certain 
limited exclusive rights to stop other people from dealing 
with their invention or works of their creation. One of the 
purposes of intellectual property is to guarantee that the 
owners of the rights so protected can maintain a market 
monopoly over their products thereby offering an opportu-
nity to recoup their investment in time and money. Patents 
cover inventions and innovations. Copyright covers works 
of artistic creation such as books, music, art, films and 
broadcasts. Trademarks cover marks, logos, etc., used in 
the course of trade. The most useful and generally utilized 
form of intellectual property protection for the products 
and processes in industry is the one provided by the gen-
eral patent law through patents. Approximately 70 - 80% 
of the world’s stores of proven, viable and directly useful 
technologies are contained in patent documents. Patent 
documents are therefore important sources of essential 
technological information. The patent system can boost 
the development of botanical medicine and enhance in-
vestment in research. It makes dissemination of technol-
ogy information possible, since no patent protection is ob-
tained unless the new technology is published thereby en-
suring industrial utilization of botanical medicines. Publi-
cation further reduces the likelihood of duplication of effort 
by others and provides a basis for further advancement of 
the technology involved. The patent system will continue 
to be the most important tool for strategic development 
and should be utilized appropriately for botanical medi-
cine development. It will stimulate the utilization of indig-
enous knowledge and serve as an instrument for licens-
ing of process and products nationally and internationally 
(Olembo & Sese 1997). 
Article 16.2 of the CBD stipulates that access to technolo-
gies shall be subject to the protection of intellectual prop-
erty rights. Although this paragraph does not discriminate 
between individual or community rights holders, it has 
been taken to apply to private rights held mostly by corpo-
rate interests. The community management system has 
always allowed reward for labour input. Any charge for the 
biomass embodying biodiversity on a unit weight or vol-
ume basis, or any monetary charge made for the technol-
ogy on a piece of hardware (an implement) basis is for 
paying for the labor used for production, not for innova-
tion, and fits in well with the community system. 
However, trying to charge for the community’s intellectual 
achievement or innovation in botanical medicine is fraught 
with difficulties. These include, among others:
(a) The problems of identifying the beneficiaries; If   
 the community as a whole is to be the beneficia 
 ry, the following problems arise:
 (i) Are all individuals in any part of the world 
 who originated from the community or 
 communities in question entitled to benefits?
 (ii) If so, will the community have the 
 organizational and the technical capacities for 
 its additional task of ensuring the inclusion of 
 all beneficiaries?
(b) If the community is to act as a single legal 
 individual in direct competition with individual 
 and corporate northern entities, additional 
 problems arise:
 (i) Raising the money required to register 
 patents (it is estimated at about 10-20 
 thousand dollars for application only 
 and requires annual payments of additional   
 amounts);
 (ii) Deploying the personnel and managing the  
 global industrial espionage system that would  
 be required to prevent unauthorized use of the  
 patented technology, and affording this 
 financially in hard currency. (It should perhaps 
 be noted that IPRs are now used in the north 
 to control markets, and preventing unauthorized  
 use of patent, usually costs more than the 
 royalties it can fetch. It is estimated that, on 
 average, maintaining a patent for its lifetime 
 in the US costs about US $250,000);
 (iii) Dealing with the near certain private patents  
 on roughly the same technology and/or 
 biodiversity which modify the community 
 technology only a little (e.g. substituting 
 extraction procedure with a different solvent).
These and many other problems arise because we are 
trying to force one system to run entirely under the norms 
of another. There is need for new innovative arrange-
ments instead of the old fashioned approach that is hardly 
flexible enough to accommodate people’s wishes. For in-
stance, the recognition and protection of proprietary rights 
in intangibles before the introduction of modern intellec-
tual property in Africa is not new (Richards 1980). That is, 
the intellectual property system though introduced by for-
eigners, does not establish completely “foreign” concepts. 
Earlier proprietary rights in intangibles vested exclusively 
in groups such as families, clans, age or sex groups, cults, 
professional guilds, or individuals such as particular el-
ders, chiefs or kings. The enforcement of these rights was 
based on magical or religious beliefs or punishments ad-
ministered by the groups. 
Traditional doctors protected their trade by a system of 
trade secrets, magical beliefs, magical practices and 
tricks. The trade secrets were maintained because, in 
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most cases, only members of their families were trained. 
This helped reinforce the belief that only that lineage had 
magical powers to heal. They demanded things like goats, 
chickens, kola nuts, and yams and often offered sacrifices 
before administering the healing. It was believed that such 
sacrifices had positive metaphysical influences on herbal 
preparations. They wielded great influences that were used 
to fight or kill those who breached the norms. This ensured 
that their art was protected. The products or skills identi-
fied the guilds, or industrial groupings such as soap making, 
black-smithery, ceramics, carving and textiles. The head of 
the guilds took large orders and represented the guild be-
fore the rulers of the community.
On the other hand intellectual property laws in industrialized 
economies were founded on sound policies. They evolved 
to resolve challenges faced by traders, guilds and the gov-
ernments in different territories. Almost every trader was 
regulated and controlled by a guild. Their goal was to foster 
the interest of the trade by controlling the activities of mem-
bers and lobbying for measures that could guarantee their 
monopoly over the trade. “People of the same trade seldom 
meet together even for a merriment or derision, but the con-
version ends in a conspiracy against the public or in some 
contrivance to raise prices” .
Access Restrictions
The most promising immediate opportunities for capturing 
greater benefits from medicinal plant biodiversity involve ac-
cess restrictions, contracts, and local value-added indus-
tries. National legislation regulating medicinal plant collect-
ing activities will provide a more formal mechanism for en-
suring that the rights of local communities are respected. 
Collecting permits should be mandatory for collectors and 
prior informed consent should be obtained before collection 
begins. The terms by which access would be given to land 
or to local knowledge must be properly negotiated.
The Organization of African Unity (OAU) at its 34th Summit 
in Ouagadougou in 1998 endorsed a model law on Commu-
nity Rights and Access to Biological Resources prepared by 
the OAU Scientific, Technical and Research Commission, 
and the government of Ethiopia. The summit passed a reso-
lution urging African countries to make their respective na-
tional laws based on the model law.
The main elements of Community Rights in the model law 
are following. They have rights to:
The protection in perpetuity (for all times) of the bio-
logical resources in their areas, their knowledge and 
technologies;
Grant access only after they have been given full infor-
mation and weighed it in advance of granting their con-
sent. This is referred to as prior informed consent;
•
•
Refuse access when they want to, and to restrict ac-
cess when they feel that giving it in full could affect 
them negatively;
Develop, keep, use, exchange, sell or share biological 
resources without any interference by governments or 
private natural or legal persons who claim IPR protec-
tion; and
Obtain at least 50% of share of benefits obtained from 
any commercial use of the biological resources in their 
areas, or benefits obtained from their knowledge and/or 
technologies.
Regardless of how they are characterized (license, permit, 
or contract) genetic resource access arrangements are es-
sentially contractual in nature. As such, contractual negotia-
tions and principles (including the concepts of prior informed 
consent and mutually agreed terms) form the basis for many 
(perhaps most) current legislative, policy and strategy docu-
ments and principles relating to access.
Nevertheless, this too has its problems. Under the CBD, the 
concept of “ownership of genetic resource” is also dicey. 
Unlike “biological resources” (an all-inclusive concept), the 
term “genetic resources” refers only to “genetic material of 
actual or potential value” (Article 2). It is generally agreed 
that the “value” of genetic resources, is in encoded genetic 
information, which may be used for a variety of purposes, 
including pharmaceutical and agricultural products develop-
ment and research. Thus, the gross mass of the biological 
material from which genetic information is developed is of 
insignificant “value” in this context compared to the informa-
tion itself.
Benefit sharing and genetic resources
The CBD assumes that when a state allows access to a 
sample of genetic resources, it is in turn entitled to insist on 
a number of benefits. It provides that research activities on 
the genetic resources have to be done in its territory to help 
it build capacity (Article 15, paragraph 6). All the informa-
tion generated by research on that genetic resource must 
be repatriated (article 17, paragraph 2). Any biotechnology 
applied on the genetic resource must be made accessible to 
its source country (Article 16, paragraph 3). A fair and equi-
table share of the benefits accruing from the use, including 
from commercial gains, of the genetic resource must also 
be given to the local community or communities and the 
state from where it was taken (Article 15, paragraph 7). But 
all this is to be conditional upon mutually agreed terms in 
the form of a contract (Article 17, paragraph 4). Many of the 
industrialized countries have been undertaking major expe-
ditions in the South to collect genetic resources even after 
the CBD came into force.
The real benefits obtained depend on the legislation in each 
developing country and the trained human resources and 
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developing counties, neither the legislation nor the sys-
tems of enforcement are in place. 
Conclusions
There is an urgent need to bridge the gap between the 
increasing interest in medicinal plants and their conser-
vation. The situation in which practitioners prepare their 
medicines and administer them without reference to any 
standard or universal protocol is inimical to the survival 
of medicinal plant species. Issues of poverty, standard-
ization, research and development, information and doc-
umentation, education and awareness need to be ad-
dressed in order check this threat. The framework laid 
down in the principles of the CBD is appropriate and 
should be adopted to guide ownership and sustainability 
issues in botanical medicine development. However, IPR 
in its present form may not permit the local communities 
to capture the full benefits of the utilization of medicinal 
plants and their conservation. Novel benefit sharing ar-
rangements should be developed at national levels, bear-
ing in mind cultural and traditional norms of the local com-
munities. There is opportunity to carry development to the 
countryside through the development of conservation and 
sustainable use programmes for medicinal plants. Sus-
tainable use systems should therefore be evolved at na-
tional and community levels, which will guarantee that the 
local people do realize benefits from medicinal plants re-
sources and this will in turn encourage them to promote 
medicinal plant conservation. R&D institutions should be 
able to negotiate directly with local communities within the 
provisions of national laws, so as to facilitate the direct 
benefits and returns on medicinal plant prospecting. De-
veloping countries need to be assisted in developing ac-
cess and benefit sharing legislations and in the training of 
appropriate manpower for enforcement. 
The processes of documentation and standardization 
must be addressed urgently through adequate funding 
of R&D, in order to identify, quantify and regulate the uti-
lization of medicinal plants in botanical medicine. There 
is need to develop the right caliber of manpower and to 
strengthen indigenous capacity in biotechnology through 
mass education, training and awareness, for medicinal 
plant conservation. 
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